IndiaInfoline » Markets » AUROPHARMA

Aurobindo Pharma Ltd - Share Price

AUROPHARMA

Open

980.00

Prev. Close

965.90

Turnover (lac.)

68,735

Day's High

1,006.25

Day's Low

976.50

52 Week's High

1,023.70

52 Week's Low

525.50

Book Value

261

Face Value

1

Mkt Cap (Cr.)

57,850

P/E

19.4

EPS

50.89

Divi. Yield

0.3

Aurobindo Pharma LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Aurobindo Pharma LtdNews & Updates

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd645.1552.15154,769.10555.550.623,366.01106.10
Divis Laboratories Ltd3,779.7054.05100,448.00461.240.421,656.48313.47
Dr Reddys Laboratories Ltd5,156.7536.0585,710.93443.700.483,397.50979.36
Cipla Ltd949.3028.7876,557.56698.930.423,689.88233.60
Aurobindo Pharma Ltd987.3019.4057,855.58740.510.303,701.14246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Aurobindo Pharma LtdSummary & Reports

Aurobindo Pharma Limited (APL), one of the worlds top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company. Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it. APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulation... More

Registered Office

Plot No 2 Maitrivihar,Behind Maithri Vanam Ameerpet,Hyderabad, Telangana,500038

Tell. : +91-40-23736370
Website : http://www.aurobindo.com
Email : info@aurobindo.com/investorgrievances@aurobindo.co

Registrar Office

Karvy Selenium Tow-B, Nanakramguda, Hyderabad-500032 INDIA

Tell. : +91-40-67162222
Website : www.kfintech.com
Email : einward.ris@kfintech.com

Latest Release by aurobindo-pharma-ltd-share-price

View

- <

Reco. Price

Apr 19,2021 03:38 PM

Target Price

Target Returns:

0.00%

Result Express

Aurobindo Pharma Ltd's Q3FY19 consolidated net profit rises 19.7% yoy to Rs712.22cr : Beats Estimates

Apr 20, 2021 10:01 PM

The company’s consolidated revenue stood at Rs5,269.67cr, up 21.53% yoy and 10.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    27 Feb 2021

    Annc. Date

    27 Feb 2021

    The Board of Directors of Aurobindo Pharma Limited (the Company) at its meeting held today i.e. Febr... More

  • Purpose

    Dividend

    Annc. Date

    10 Feb 2021

    Effective. Date

    22 Feb 2021

    Divi. Type

    Interim 3

    Divi.(%)

    150

    Divi. Amt.

    1.5

    The Board of Directors of the Company at its meeting held today, February 10, 2021, has, inter alia,... More

  • Purpose

    Board Meeting

    Exp. Date

    10 Feb 2021

    Annc. Date

    01 Feb 2021

    AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is s... More